Terms: = Lung cancer AND CREB1, ENSG00000118260, 1385 AND Treatment
18 results:
1. Primary pulmonary myxoid sarcoma with EWSR1::creb1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H
J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
[TBL] [Abstract] [Full Text] [Related]
2. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma.
Liang J; Bi G; Huang Y; Zhao G; Sui Q; Zhang H; Bian Y; Yin J; Wang Q; Chen Z; Zhan C
Drug Resist Updat; 2024 Mar; 73():101057. PubMed ID: 38266355
[TBL] [Abstract] [Full Text] [Related]
3. [Rare case of primary pulmonary myxoid sarcoma].
Robotka Z; Szabó KG; Tóth I; Szöllősi Z; Barna T; Pápai-Székely Z; Grmela G; Slárku I; Csánky E
Orv Hetil; 2023 Jul; 164(27):1077-1083. PubMed ID: 37422888
[TBL] [Abstract] [Full Text] [Related]
4. miR-125b-5p upregulation by TRIM28 induces cisplatin resistance in non-small cell lung cancer through creb1 inhibition.
Tan Q; Ma J; Zhang H; Wu X; Li Q; Zuo X; Jiang Y; Liu H; Yan L
BMC Pulm Med; 2022 Dec; 22(1):469. PubMed ID: 36476351
[TBL] [Abstract] [Full Text] [Related]
5. National trends in the quality of segmentectomy for lung cancer.
Logan CD; Jacobs RC; Feinglass J; Lung K; Kim S; Bharat A; Odell DD
J Thorac Cardiovasc Surg; 2023 Jan; 165(1):351-363.e20. PubMed ID: 36088143
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3-4 NSCLC patients.
Li C; Tian C; Zeng Y; Liang J; Yang Q; Gu F; Hu Y; Liu L
BMC Med Genomics; 2022 Feb; 15(1):33. PubMed ID: 35193578
[TBL] [Abstract] [Full Text] [Related]
7. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence.
Pawar S; Liew TO; Stanam A; Lahiri C
Chem Biol Drug Des; 2020 Sep; 96(3):995-1004. PubMed ID: 32410355
[TBL] [Abstract] [Full Text] [Related]
8. Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study.
Kakkos SK; Arnaoutoglou E; Tsolakis IA; Giannoukas A; Papadimitriou CA; Kentepozidis N; Boukovinas I; Kalofonos HP; Labropoulos N; Matsagkas M
Int Angiol; 2020 Apr; 39(2):112-117. PubMed ID: 32057213
[TBL] [Abstract] [Full Text] [Related]
9. Acquired SETD2 mutation and impaired creb1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.
Kim IK; McCutcheon JN; Rao G; Liu SV; Pommier Y; Skrzypski M; Zhang YW; Giaccone G
Oncogene; 2019 Jan; 38(2):180-193. PubMed ID: 30093630
[TBL] [Abstract] [Full Text] [Related]
10. Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancer.
Lee Y; Park S; Kim WS; Lee JC; Jang SJ; Choi J; Choi CM
Thorac Cancer; 2018 Sep; 9(9):1104-1110. PubMed ID: 29989342
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer.
Feng S; Zhang J; Su W; Bai S; Xiao L; Chen X; Lin J; Reddy RM; Chang AC; Beer DG; Chen G
Sci Rep; 2017 Jun; 7(1):2982. PubMed ID: 28592840
[TBL] [Abstract] [Full Text] [Related]
12. In silico identification of potential key regulatory factors in smoking-induced lung cancer.
El-Aarag SA; Mahmoud A; Hashem MH; Abd Elkader H; Hemeida AE; ElHefnawi M
BMC Med Genomics; 2017 Jun; 10(1):40. PubMed ID: 28592245
[TBL] [Abstract] [Full Text] [Related]
13. No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell lung cancer: A Literature-Based Meta-Analysis of Randomized Trials.
Roviello G; Zanotti L; Cappelletti MR; Gobbi A; Senti C; Bottini A; Generali D
Clin Lung Cancer; 2016 Sep; 17(5):334-340. PubMed ID: 27346522
[TBL] [Abstract] [Full Text] [Related]
14. Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
Bilen MA; Patel A; Hess KR; Munoz J; Busaidy NL; Wheler JJ; Janku F; Falchook GS; Hong DS; Meric-Bernstam F; Habra MA; Naing A
Cancer Chemother Pharmacol; 2016 Jul; 78(1):167-71. PubMed ID: 27286994
[TBL] [Abstract] [Full Text] [Related]
15. Chemosensitizing effect of podophyllotoxin acetate on topoisomerase inhibitors leads to synergistic enhancement of lung cancer cell apoptosis.
Hong WG; Cho JH; Hwang SG; Lee E; Lee J; Kim JI; Um HD; Park JK
Int J Oncol; 2016 Jun; 48(6):2265-76. PubMed ID: 27035096
[TBL] [Abstract] [Full Text] [Related]
16. Γ-Ionizing radiation-induced activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate.
Cho JH; Hong WG; Jung YJ; Lee J; Lee E; Hwang SG; Um HD; Park JK
Tumour Biol; 2016 Jun; 37(6):7315-25. PubMed ID: 26671552
[TBL] [Abstract] [Full Text] [Related]
17. Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant Mesothelioma.
Yamada T; Amann JM; Fukuda K; Takeuchi S; Fujita N; Uehara H; Iwakiri S; Itoi K; Shilo K; Yano S; Carbone DP
Cancer Res; 2015 Oct; 75(19):4188-97. PubMed ID: 26294214
[TBL] [Abstract] [Full Text] [Related]
18. Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation.
Lo HW; Ali-Osman F
J Cell Biochem; 2002; 87(1):103-16. PubMed ID: 12210727
[TBL] [Abstract] [Full Text] [Related]
